Cargando…

Social Network Structure and Atherosclerotic Cardiovascular Disease

Detalles Bibliográficos
Autor principal:	Nishi, Nobuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Atherosclerosis Society 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827080/ https://www.ncbi.nlm.nih.gov/pubmed/29057761 http://dx.doi.org/10.5551/jat.ED087

Ejemplares similares

Cholesterol and Atherosclerotic Cardiovascular Disease: A Lifelong Problem
por: Gidding, Samuel S., et al.
Publicado: (2019)

SIRT1 and Gender Differences in Atherosclerotic Cardiovascular Disease
por: Shimabukuro, Michio
Publicado: (2020)

A Risk Prediction Model of Atherosclerotic Cardiovascular Disease in Japan
por: Saito, Isao
Publicado: (2022)

Atherosclerotic Cardiovascular Disease: Risk Assessment, Prevention and Treatment Strategies
por: Jeras, Jernej, et al.
Publicado: (2022)

New guidelines and evidence for prevention and treatment of dyslipidemia and atherosclerotic cardiovascular disease in China()
por: Hu, Da-Yi
Publicado: (2016)

Is Lipoprotein(a) the Most Important Predictor of Residual Atherosclerotic Cardiovascular Disease Risk?
por: Wong, Nathan D.
Publicado: (2022)

Carotid atherosclerotic disease
por: Sitrângulo, Cid José, et al.
Publicado: (2018)

L-Arginine, Nitric Oxide, and Endothelial Dysfunction Underlying Atherosclerotic Cardiovascular Disease (ASCVD)
por: Shimabukuro, Michio
Publicado: (2023)

Apolipoprotein B, Non-HDL Cholesterol, and LDL Cholesterol as Markers for Atherosclerotic Cardiovascular Disease Risk Assessment
por: Yun, Yeo-Min
Publicado: (2023)

Implication of new atherosclerotic carotid plaques in the cardiovascular outcome of patients with rheumatoid arthritis
por: González-Gay, Miguel A, et al.
Publicado: (2012)

Inflammation in atherosclerotic cardiovascular disease
por: Shah, Prediman K., et al.
Publicado: (2019)

Genetic Variations, Triglycerides, and Atherosclerotic Disease
por: Tada, Hayato, et al.
Publicado: (2019)

Can Barker's Hypothesis Explain the Observed Different Trends of Mortality from Atherosclerotic Cardiovascular Disease in Western Europe?
por: Ghafari, Mahin, et al.
Publicado: (2013)

Editorial: The 2021 European Society of Cardiology (ESC) Guidelines on the Real-World Prevention of Atherosclerotic Cardiovascular Disease (ASCVD)
por: Parums, Dinah V.
Publicado: (2021)

Modulating inflammation to reduce atherosclerotic cardiovascular events: should colchicine be part of the therapeutic regimen?
por: Jialal, Ishwarlal, et al.
Publicado: (2021)

Advances in Cardiovascular Pharmacology in Atherosclerotic-Related Therapeutic Areas: Addressing Patients’ Clinical Needs
por: Omari, Muntaser, et al.
Publicado: (2023)

The Ratio of Triglyceride to High-density Lipoprotein Cholesterol as an Indicator of Risk Stratification for Atherosclerotic Cardiovascular Disease in a Clinical Setting
por: Tani, Shigemasa
Publicado: (2020)

Androgen therapy and atherosclerotic cardiovascular disease
por: McGrath, K-CY, et al.
Publicado: (2008)

Atherosclerotic Cardiovascular Disease Beginning in Childhood
por: Hong, Young Mi
Publicado: (2010)

The gut microbiome in atherosclerotic cardiovascular disease
por: Jie, Zhuye, et al.
Publicado: (2017)

Another Unmet Need against Residual Risk of Atherosclerotic Cardiovascular Disease: Can “Thrombin Pathway” Be a New Target for Therapy?
por: Kim, Hyun Kuk, et al.
Publicado: (2020)

Performance of the Atherosclerotic Cardiovascular Disease Pooled Cohort Risk Equations by Social Deprivation Status
por: Colantonio, Lisandro D., et al.
Publicado: (2017)

Oxidative Stress Underpins Clinical, Social, and Genetic Risk Factors for Atherosclerotic Cardiovascular Disease
por: Mewborn, Emily, et al.
Publicado: (2023)

Cardiovascular Imaging for the Primary Prevention of Atherosclerotic Cardiovascular Disease Events
por: Weber, Lauren A., et al.
Publicado: (2015)

Preventing Atherosclerotic Cardiovascular Disease Using American College of Cardiology and American Heart Association Prevention Guidelines: Some Good News, But Caveats Remain
por: Stone, Neil J.
Publicado: (2016)

Cysteine Protease Cathepsins in Atherosclerotic Cardiovascular Diseases
por: Wu, Hongxian, et al.
Publicado: (2018)

Inflammatory Biomarkers and Risk of Atherosclerotic Cardiovascular Disease
por: Yu, En, et al.
Publicado: (2018)

Cardiovascular magnetic resonance in carotid atherosclerotic disease
por: Dong, Li, et al.
Publicado: (2009)

Incidence of cancers in patients with atherosclerotic cardiovascular diseases
por: Suzuki, Makoto, et al.
Publicado: (2017)

Current Findings from the Japan National Health and Nutrition Survey
por: Nishi, Nobuo, et al.
Publicado: (2023)

Renal artery stenting in the correct patients with atherosclerotic renovascular disease: time for a proper renal and cardiovascular outcome study?
por: Theodorakopoulou, Marieta P, et al.
Publicado: (2022)

Scope and Social Determinants of Food Insecurity Among Adults With Atherosclerotic Cardiovascular Disease in the United States
por: Mahajan, Shiwani, et al.
Publicado: (2021)

Atherosclerotic and Cardio-Metabolic Diseases: From Molecular Basis to Therapeutic Advances
por: Kassi, Eva, et al.
Publicado: (2023)

Number of Missing Teeth as a Surrogate Marker for Risk of Atherosclerotic Disease
por: Ono, Takahiro
Publicado: (2023)

Atherosclerotic Cardiovascular Risk in Japan
por: Nojiri, Shuko, et al.
Publicado: (2017)

Risk stratification of atherosclerotic cardiovascular disease in Chinese adults
por: Yang, Xue-Li, et al.
Publicado: (2016)

Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease
por: Shapiro, Michael D., et al.
Publicado: (2017)

Risk of Atherosclerotic Cardiovascular Diseases in various Ethnicities of Pakistan
por: Ashraf, Tariq, et al.
Publicado: (2020)

HDL in Atherosclerotic Cardiovascular Disease: In Search of a Role
por: Casula, Manuela, et al.
Publicado: (2021)

Oral health and atherosclerotic cardiovascular disease: A review
por: Gianos, Eugenia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_289v1bh701rucupru8skdk82q6